Skip to main content
. 2021 Apr 13;16:77. doi: 10.1186/s13019-021-01455-5

Table 2.

Peri- and postoperative outcomes of r-VATS for different surgical operations

Type of surgical operations No. of patients (n) Diagnosis Pathology (n) Median operative time (range); in minutes Conversion rate for each surgery (%) Median duration of hospital stay (range); in days
Lobectomy 66 Tumors in the right upper or lower lobes (RUL/RLL) and the left upper or lower lobes (LUL/LLL) of the lungs/ LLL bronchiectasis Malignant adenocarcinoma (63) and malignant squamous cell carcinoma (3) 120 (80–220) NA 5 (3–16)
Wedge resection 15 LUL/RUL/LLL/RLL/LU + LL tumor Benign inflammation (13) and tuberculosis (2) 60 (50–80) NA 3 (2–4)
Thymectomy 22 Thymoma/Myasthenia gravis/ Thymoma+Myasthenia gravis Benign myasthenia (19) and myasthenia +small thymoma (3) 80 (60–180) NA 4 (3–10)
Mediastinal tumor resection 30 Mediastinal tumor

Posterior benign neurogenic tumors (9), posterior paratracheal benign cyst (2),

invasive thymoma (12)

thymic carcinomas (7; one converted to open)

110 (60–190) 3.33 4 (3–8)
Pneumonectomy 4 LLL/LUL/RLL tumor Malignant adenocarcinoma (4) 157.50 (95–220) 50 6.5 (4–10)
Transthoracic esophagectomy 1 Esophageal tumor Malignant squamous cell carcinoma (1) 280 NA 12
Esophageal tumor resection/ Esophageal diverticulum repair 2 Esophageal leiomyoma Benign (2) 115 (110–120) NA 4.5 (4–5)
Diaphragm plication 1 Elevated diaphragm NA 70 NA 3
Mediastinal tumor resection plus thymectomy 1 Thymoma Benign (1) 100 NA 6